MYGN.NASDAQMyriad Genetics INC
Form 4: Myriad Genetics Executive Shereen Solaiman Reports Stock Transaction
Sentiment:
SEC Form 4 Filing
Chief People Officer Shereen Solaiman of Myriad Genetics reports the withholding of shares to cover tax obligations related to vested restricted stock units.
Summary
- On March 1, 2024, Shereen Solaiman, Chief People Officer of Myriad Genetics, had 1,108 shares of common stock withheld by the company to cover tax obligations.
- This transaction occurred in connection with the vesting of restricted stock units.
- The shares were withheld at a price of $22.18 per share.
- Following the transaction, Solaiman directly owns 14,748 shares of Myriad Genetics stock.
Sentiment
Score: 5
Explanation: The document reports a routine transaction related to tax obligations, which is neutral in sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock transaction (share withholding for tax obligations). |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.